Embryonic rhabdomyosarcoma is a highly malignant cancer that affects children under 15, caused by out-of-control embryonic cells. It is most common in the head, neck, and eyes, and is treated with surgery, radiation, and chemotherapy. Prognosis depends on age and location of the tumor.
Embryonic rhabdomyosarcoma is a rapidly growing, highly malignant type of cancer that usually affects children under the age of 15. This type of tumor is particularly aggressive and tends to grow back unless it is completely eradicated. The prognosis for survival varies depending on the child’s age and the location and size of the mass.
In children, embryonic rhabdomyosarcoma is the most common type of soft tissue sarcoma. It occurs when embryonic cells called rhabdomyoblasts, which are the cells that eventually develop into skeletal muscle tissue, grow out of control and instead turn into cancerous tumors. Rhabdomyosarcoma tumors can grow in almost any part of the body except the brain.
This type of cancer usually occurs in four predominant areas of the body. It occurs most often around the head, neck and eyes. Rhabdomyosarcoma tumors can also form in the urinary tract and genital region, arms and legs, or the lungs and chest.
Males have slightly higher rates of developing this type of cancer than females. While all races are at risk, Asians are somewhat less susceptible than blacks or whites. The disease does not occur in any specific geographic region.
Symptoms of embryonic rhabdomyosarcoma might include a droopy eyelid or a bulging eye if the tumor is around the eyes. Patients may experience bleeding or pain in the nose, throat, or genitals, or they may have tingling, pain, or lack of sensation in the affected area. The patient may also have an obvious tumor or growth.
The doctor will perform a biopsy to determine if the patient has cancer. He or she will also perform a variety of other tests, such as X-rays, bone scans, a bone marrow biopsy, and computed tomography (CT) scans. Your doctor might also look inside your body by doing ultrasound or magnetic resonance imaging (MRI) tests. Embryonic rhabdomyosarcoma is treated by surgically removing the tumor, giving radiation or chemotherapy, or through a combination of approaches.
Embryonic rhabdomyosarcoma is the most treatable form of rhabdomyosarcoma, depending on the patient’s age and location of the tumor. Children younger than 12 months have a generally poor prognosis. Patients whose tumors are found in the genital, head and neck area have higher survival rates than children whose tumors form in other areas of the body. The prognosis for embryonic rhabdomyosarcoma is generally good as long as the cancer has not metastasized or spread to other areas of the body.
Protect your devices with Threat Protection by NordVPN
